Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Crowther

Showing results (251-260 of 286) with videos related to

Pageof 29
Sort By:
The Journal of Biological Chemistry|October 26, 2017
Autoantibodies against the cell surface-associated chaperone GRP78 stimulate tumor growth via tissue factorAli A Al-Hashimi, Paul Lebeau, Fadwa Majeed, et al.
Anesthesiology|March 16, 2018
Comparison of Two Major Perioperative Bleeding Scores for Cardiac Surgery Trials: Universal Definition of Perioperative Bleeding in Cardiac Surgery and European Coronary Artery Bypass Grafting Bleeding Severity GradeJustyna Bartoszko, Duminda N Wijeysundera, Keyvan Karkouti, et al.
The Journal of Biological Chemistry|August 15, 2025
Correction: Autoantibodies against the cell surface-associated chaperone GRP78 stimulate tumor growth via tissue factorAli A Al-Hashimi, Paul Lebeau, Fadwa Majeed, et al.
Chest|June 22, 2013
Thrombocytopenia in critically ill patients receiving thromboprophylaxis: frequency, risk factors, and outcomesDavid R Williamson, Martin Albert, Diane Heels-Ansdell, et al.
Stroke|May 7, 2026
Predictors of Hematoma Expansion and Response to Andexanet in Patients With Intracerebral Hemorrhage: Secondary Analyses of the ANNEXA-I Randomized Clinical TrialAshkan Shoamanesh, Stuart J Connolly, Andrew M Demchuk, et al.
Thrombosis Journal|January 2, 2019
Rivaroxaban versus standard anticoagulation for acute venous thromboembolism in childhood. Design of the EINSTEIN-Jr phase III studyAnthonie W A Lensing, Christoph Male, Guy Young, et al.
Journal of Critical Care|November 29, 2005
Prophylaxis of Thromboembolism in Critical Care (PROTECT) Trial: a pilot studyDeborah J Cook, Graeme Rocker, Maureen Meade, et al.
Annals of Internal Medicine|June 5, 2013
Aspirin versus low-molecular-weight heparin for extended venous thromboembolism prophylaxis after total hip arthroplasty: a randomized trialDavid R Anderson, Michael J Dunbar, Eric R Bohm, et al.
Canadian Respiratory Journal|October 2, 2013
Prediction scores do not correlate with clinically adjudicated categories of pulmonary embolism in critically ill patientsChristina Katsios, Marco Donadini, Maureen Meade, et al.
Journal of Critical Care|April 15, 2014
Heparin-induced thrombocytopenia in the critically ill: interpreting the 4Ts test in a randomized trialMark Crowther, Deborah Cook, Gordon Guyatt, et al.
Pageof 29

Showing results (251-260 of 286) with videos related to

Sort By:
Pageof 29
The Journal of Biological Chemistry|October 26, 2017
Autoantibodies against the cell surface-associated chaperone GRP78 stimulate tumor growth via tissue factorAli A Al-Hashimi, Paul Lebeau, Fadwa Majeed, et al.
Anesthesiology|March 16, 2018
Comparison of Two Major Perioperative Bleeding Scores for Cardiac Surgery Trials: Universal Definition of Perioperative Bleeding in Cardiac Surgery and European Coronary Artery Bypass Grafting Bleeding Severity GradeJustyna Bartoszko, Duminda N Wijeysundera, Keyvan Karkouti, et al.
The Journal of Biological Chemistry|August 15, 2025
Correction: Autoantibodies against the cell surface-associated chaperone GRP78 stimulate tumor growth via tissue factorAli A Al-Hashimi, Paul Lebeau, Fadwa Majeed, et al.
Chest|June 22, 2013
Thrombocytopenia in critically ill patients receiving thromboprophylaxis: frequency, risk factors, and outcomesDavid R Williamson, Martin Albert, Diane Heels-Ansdell, et al.
Stroke|May 7, 2026
Predictors of Hematoma Expansion and Response to Andexanet in Patients With Intracerebral Hemorrhage: Secondary Analyses of the ANNEXA-I Randomized Clinical TrialAshkan Shoamanesh, Stuart J Connolly, Andrew M Demchuk, et al.
Thrombosis Journal|January 2, 2019
Rivaroxaban versus standard anticoagulation for acute venous thromboembolism in childhood. Design of the EINSTEIN-Jr phase III studyAnthonie W A Lensing, Christoph Male, Guy Young, et al.
Journal of Critical Care|November 29, 2005
Prophylaxis of Thromboembolism in Critical Care (PROTECT) Trial: a pilot studyDeborah J Cook, Graeme Rocker, Maureen Meade, et al.
Annals of Internal Medicine|June 5, 2013
Aspirin versus low-molecular-weight heparin for extended venous thromboembolism prophylaxis after total hip arthroplasty: a randomized trialDavid R Anderson, Michael J Dunbar, Eric R Bohm, et al.
Canadian Respiratory Journal|October 2, 2013
Prediction scores do not correlate with clinically adjudicated categories of pulmonary embolism in critically ill patientsChristina Katsios, Marco Donadini, Maureen Meade, et al.
Journal of Critical Care|April 15, 2014
Heparin-induced thrombocytopenia in the critically ill: interpreting the 4Ts test in a randomized trialMark Crowther, Deborah Cook, Gordon Guyatt, et al.
Pageof 29